R. Lor Randall

11.9k total citations · 1 hit paper
203 papers, 4.4k citations indexed

About

R. Lor Randall is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, R. Lor Randall has authored 203 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Pulmonary and Respiratory Medicine, 65 papers in Surgery and 60 papers in Oncology. Recurrent topics in R. Lor Randall's work include Sarcoma Diagnosis and Treatment (125 papers), Bone Tumor Diagnosis and Treatments (31 papers) and Management of metastatic bone disease (28 papers). R. Lor Randall is often cited by papers focused on Sarcoma Diagnosis and Treatment (125 papers), Bone Tumor Diagnosis and Treatments (31 papers) and Management of metastatic bone disease (28 papers). R. Lor Randall collaborates with scholars based in United States, Canada and Netherlands. R. Lor Randall's co-authors include Stephen L. Lessnick, Kevin B. Jones, Richard Görlick, Neyssa Marina, Alana L. Welm, Karen Albritton, Yi‐Chun Lin, Saundra S. Buys, Philip S. Bernard and Bryan E. Welm and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

R. Lor Randall

193 papers receiving 4.3k citations

Hit Papers

Tumor grafts derived from women with breast cancer authen... 2011 2026 2016 2021 2011 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Lor Randall United States 35 2.1k 1.4k 1.1k 916 801 203 4.4k
Sam S. Yoon United States 46 2.4k 1.2× 2.1k 1.4× 1.7k 1.5× 871 1.0× 772 1.0× 120 5.4k
Gian Luca De Salvo Italy 39 1.5k 0.7× 1.7k 1.2× 660 0.6× 1.2k 1.3× 909 1.1× 135 4.3k
Najat C. Daw United States 40 2.7k 1.3× 1.2k 0.8× 1.4k 1.3× 724 0.8× 509 0.6× 154 4.7k
Salvatore Lo Vullo Italy 35 2.4k 1.2× 2.3k 1.6× 785 0.7× 1.4k 1.6× 620 0.8× 79 4.9k
Uta Dirksen Germany 38 3.6k 1.7× 1.5k 1.1× 1.5k 1.3× 976 1.1× 776 1.0× 190 5.8k
Catherine A. Billups United States 48 2.5k 1.2× 1.8k 1.2× 2.0k 1.7× 856 0.9× 619 0.8× 165 6.0k
Rashmi Chugh United States 39 2.5k 1.2× 2.1k 1.5× 1.5k 1.3× 432 0.5× 547 0.7× 172 4.9k
Akitaka Nonomura Japan 39 1.6k 0.8× 1.5k 1.0× 746 0.7× 1.7k 1.8× 561 0.7× 284 6.2k
Karen J. Marcus United States 40 2.5k 1.2× 1.1k 0.7× 1.1k 1.0× 847 0.9× 308 0.4× 144 5.6k
Heimen Schraffordt Koops Netherlands 38 1.7k 0.8× 1.4k 1.0× 767 0.7× 1.8k 2.0× 295 0.4× 134 4.7k

Countries citing papers authored by R. Lor Randall

Since Specialization
Citations

This map shows the geographic impact of R. Lor Randall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Lor Randall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Lor Randall more than expected).

Fields of papers citing papers by R. Lor Randall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Lor Randall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Lor Randall. The network helps show where R. Lor Randall may publish in the future.

Co-authorship network of co-authors of R. Lor Randall

This figure shows the co-authorship network connecting the top 25 collaborators of R. Lor Randall. A scholar is included among the top collaborators of R. Lor Randall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Lor Randall. R. Lor Randall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bernthal, Nicholas M., Sean O’Neill, Emanuela Palmerini, et al.. (2025). Localized and diffuse tenosynovial giant cell tumor: real-world results from a patient observational registry. Future Oncology. 21(12). 1501–1510. 1 indexed citations
2.
Chavez, Gilda, et al.. (2024). Musculoskeletal Tumor Society Member Survey: Intra‐Operative Peripheral Margins in Soft Tissue Sarcoma. Journal of Surgical Oncology. 131(4). 699–702.
3.
Chávez, Guadalupe, Machelle Wilson, Morgan Darrow, et al.. (2024). Intraoperative Peripheral Frozen Margin Assessment in Soft Tissue Sarcoma. Journal of Surgical Oncology. 131(4). 694–698.
5.
Staals, Eric L., Emanuela Palmerini, R. Lor Randall, et al.. (2024). Active surveillance of diffuse-type tenosynovial giant cell tumors: A retrospective, multicenter cohort study. European Journal of Surgical Oncology. 50(2). 107953–107953. 3 indexed citations
6.
Freeland, Jack, Edmond F. O’Donnell, Justin Langerman, et al.. (2024). Genetic Screen in a Preclinical Model of Sarcoma Development Defines Drivers and Therapeutic Vulnerabilities. Clinical Cancer Research. 30(21). 4957–4973. 1 indexed citations
8.
Randall, R. Lor, et al.. (2023). Emerging innovations and advancements in the field of musculoskeletal oncology. Journal of Surgical Oncology. 128(3). 415–417. 2 indexed citations
9.
Jawad, Muhammad Umar, et al.. (2023). Socioeconomic disparities in musculoskeletal oncology. Journal of Surgical Oncology. 128(3). 425–429. 1 indexed citations
10.
Ghosh, P., et al.. (2023). The dynamic microenvironment associated with metastatic bone disease: Current concepts. Journal of Surgical Oncology. 128(3). 468–477. 2 indexed citations
11.
Tap, William D., Bryan D. Smith, Matthew L. Sherman, et al.. (2023). The MOTION Study: A Randomized, Phase III Study of Vimseltinib for the Treatment of Tenosynovial Giant Cell Tumor. Future Oncology. 20(10). 593–601. 6 indexed citations
12.
Hingorani, Pooja, Mark Krailo, Allen Buxton, et al.. (2022). Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology Group. European Journal of Cancer. 172. 264–275. 23 indexed citations
13.
Jawad, Muhammad Umar, et al.. (2021). Malignant neoplasms originating from the bones of the foot: Predilection of hematological malignancies and sex‐related and ethnic disparities in amputation. Journal of Surgical Oncology. 124(8). 1468–1476. 2 indexed citations
14.
Blank, Alan T., et al.. (2021). Metastasis of Osteosarcoma to the Abdomen: A Report of Two Cases and a Review of the Literature. Case Reports in Oncology. 14(1). 647–658. 3 indexed citations
15.
Jawad, Muhammad Umar, et al.. (2021). Primary mobile vertebral column sarcomas: Prognostic factors vary by histologic subtypes. Journal of Surgical Oncology. 124(4). 635–645. 5 indexed citations
16.
17.
Gerrand, Craig, Jessica Bate, Beatrice Seddon, et al.. (2020). Seeking international consensus on approaches to primary tumour treatment in Ewing sarcoma. PubMed. 10(1). 21–21. 14 indexed citations
18.
Jones, Kevin B., Zaidoun Salah, Sara Del Mare, et al.. (2012). miRNA Signatures Associate with Pathogenesis and Progression of Osteosarcoma. Cancer Research. 72(7). 1865–1877. 301 indexed citations
19.
Calvert, George T., R. Lor Randall, Kevin B. Jones, et al.. (2012). At-Risk Populations for Osteosarcoma: The Syndromes and Beyond. Sarcoma. 2012. 1–9. 59 indexed citations
20.
Nishijo, Koichi, Qingrong Chen, Lei Zhang, et al.. (2009). Credentialing a Preclinical Mouse Model of Alveolar Rhabdomyosarcoma. Cancer Research. 69(7). 2902–2911. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026